{"id":386605,"date":"2018-06-27T00:00:00","date_gmt":"2018-06-27T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/m360gy0038-medtech-gynecological-devices-market-insights-us-2019\/"},"modified":"2026-04-27T11:08:12","modified_gmt":"2026-04-27T11:08:12","slug":"m360gy0038-medtech-gynecological-devices-market-insights-us-2019","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/m360gy0038-medtech-gynecological-devices-market-insights-us-2019\/","title":{"rendered":"Gynecological Devices | Market Insights | US | 2019"},"content":{"rendered":"<p>Growth in the US market for gynecological devices will be driven primarily by product improvements in the\u00a0<abbr title=\"Global Endometrial Ablation\">GEA<\/abbr>\u00a0device, hormonal\u00a0<abbr title=\"Intrauterine Device\">IUD<\/abbr>, and hysterscopic morcellator markets. The market will also be fueled by the adoption of devices used in office-based procedures\u2014including hormonal\u00a0<abbr title=\"Assisted Reproduction Consumable\">ARC<\/abbr>\u00a0devices,\u00a0<abbr title=\"Global Endometrial Ablation\">GEA<\/abbr>\u00a0devices, fluid management devices, and hysteroscopic morcellators\u2014due to growing awareness of less invasive treatment options for various gynecological conditions. The market will be limited by safety issues that lead to product recalls of major products on the market.\u00a0<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for gynecological devices in the US\u00a0across a 10-year period.<\/p>\n","protected":false},"template":"","class_list":["post-386605","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-gynecological-devices","medtech-therapy-area-gynecology","medtech-date-918"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386605","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386605\/revisions"}],"predecessor-version":[{"id":388107,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386605\/revisions\/388107"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=386605"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}